<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00526448</url>
  </required_header>
  <id_info>
    <org_study_id>2006-005940-99</org_study_id>
    <nct_id>NCT00526448</nct_id>
  </id_info>
  <brief_title>Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients</brief_title>
  <acronym>PERICO</acronym>
  <official_title>Open, Multicentre,Randomized Phase IV Trial to Evaluate Efficacy/Safety to Extend Treatment Duration With Peginterferon Alfa-2a+High Dose of Ribavirin Supporting Epo β in Treatment of CHC in HIV-HCV Patients Who Not Clear Virus at Week 4</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Carlos III, Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Carlos III, Madrid</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the sustained virological response (SVR = ribonucleic acid (RNA) - hepatitis C
      virus (HCV) undetectable at week 24 before end the treatment) in chronic hepatitis C patients
      genotype 1-4 co-infected with HIV-HCV, treated with Peginterferón alfa-2a (40 KD) 180 µg/week
      and Ribavirin (2000 mg/day during 4 weeks, follow of 1000-1200 mg/day, according to body
      weight); versus Peginterferón alfa-2a (40 KD) 180 μg/week and Ribavirin (1000-1200 mg/day,
      according to body weight).

      To evaluate the impact to extend the treatment with Peginterferon alfa-2a and Ribavirin to
      week 72, in SVR of these patients with genotypes 1-4 without rapid virological response (RVR
      = RNA - HCV undetectable at 4 week).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The PRESCO study (ribavirin dose 1000-1200 mg/day) emphasized that optimal ribavirin exposure
      seems to be crucial to maximize sustained virological response and minimize the incidence of
      relapses after treatment discontinuations.

      Recent reports showed that it is beneficial to extend the treatment duration in patients
      without rapid virological response at 4 weeks (RNA-HCV &lt; 50 UI/ml).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2007</start_date>
  <completion_date type="Anticipated">February 2010</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>% patients with RNA-HCV &lt; 50 UI/ml</measure>
    <time_frame>24 weeks after the end of treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>% patients with RNA-HCV &lt; 50 UI/ml</measure>
    <time_frame>4 weeks on treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">384</enrollment>
  <condition>Chronic Hepatitis C</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Peginterferon alfa-2a 180 mcg/week + ribavirin 2000 mg/day + epoetin beta 450 UI/week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Peginterferon alfa-2a 180 mcg/week + ribavirin 1000-1200 mg/day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ribavirin</intervention_name>
    <description>2000 mg/day</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ribavirin</intervention_name>
    <description>1000-1200 mg/day</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Peginterferon alfa-2a</intervention_name>
    <description>Peginterferon alfa-2a 180 mcg/week</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>epoetin beta</intervention_name>
    <description>epoetin beta 450 UI/week</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female patients &gt; 18 years of age

          -  Serologic evidence of anti-HCV

          -  Detectable plasma HCV-RNA

          -  Serologic evidence of HIV-1 infection

          -  CD4 cell count &gt;/= 250 cell/mm3

          -  Stable status of HIV-1 infection in the opinion of the investigator

          -  Patients on stable antiretroviral therapy (HAART) for at least 6 weeks prior to
             baseline whose HAART regimen (drugs and dosage) is expected to remain unaltered for
             the first 6 weeks of this study

          -  Patients who have not been on HAART for at least 6 weeks prior to randomization who
             are willing to delay initiation of HAART therapy for at least 6 weeks

          -  Negative urine or blood pregnancy test (for women of childbearing potential)
             documented within the 24-hour period prior to the first dose of study drug

          -  Willingness to give written informed consent

        Exclusion Criteria:

          -  Women with ongoing pregnancy or breast feeding

          -  Male partners of women who are pregnant

          -  IFN/ribavirin therapy at any previous time

          -  Child Pugh &gt; 6 (Child Pugh B or C)

          -  History or conditions consistent with decompensated liver disease

          -  Any investigational drug 6 weeks prior to the first dose of study drug (expanded
             access programs for HIV treatment are allowed)

          -  Patients treated with didanosine and/or zidovudine

          -  Positive test at anti-HAV IgM Ab, HBsAg, anti-HBc IgM Ab, HBeAg

          -  History or other evidence of a medical condition associated with chronic liver disease
             other than HCV

          -  Hepatocarcinoma observed in the liver ecography

          -  Serum concentrations of ceruloplasmin or alfa1-antitrypsin at screening consistent
             with an increased risk of metabolic liver disease

          -  Active HIV-related opportunistic infection and/or malignancy requiring acute systemic
             therapy

          -  Absolute neutrophil count (ANC) &lt; 1500 cells/mm3

          -  Hgb &lt; 11 g/dL in women or 12 g/dL in men or any patient for whom anemia would be
             medically problematic

          -  Hemoglobinopathy or any other cause of or tendency for hemolysis

          -  Platelet count &lt; 50,000 cells/mm3

          -  History of G-CSF, GM-CSF or epo treatment during 3 months prior to the first dose of
             study drug

          -  Serum creatinine level &gt; 1.5 times the upper limit of normal at screening

          -  History of severe psychiatric disease, especially depression

          -  History of a severe seizure disorder or current anticonvulsant use

          -  History of immunologically mediated disease

          -  History or other evidence of chronic pulmonary disease associated with functional
             limitation

          -  History of significant cardiac disease that could be worsened by acute anemia

          -  History of thyroid disease poorly controlled on prescribed medications

          -  Evidence of severe retinopathy

          -  History of major organ transplantation with an existing functional graft

          -  History or other evidence of severe illness, malignancy or any other conditions which
             would make the patient, in the opinion of the investigator, unsuitable for the study

          -  History of any systemic anti-neoplastic or immunomodulatory treatment 6 months prior
             to the first dose of study drug or the expectation that such treatment will be needed
             at any time during the study

          -  Concomitant medication with rifampin/rifampicin, rifabutin, pyrazinamide, isoniazid,
             gancyclovir, thalidomide, oxymetholone, immunomodulatory treatments and systemic
             antiviral agents as adjuvant therapy for CHC

          -  Drug use within 6 months of 1st dose and excessive alcohol consumption
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vicente Soriano, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Carlos III. Madrid. Spain</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vicente Soriano, Dr</last_name>
    <phone>+34914532500</phone>
    <email>vsoriano@dragonet.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pablo Barreiro, Dr</last_name>
    <phone>+34914532500</phone>
    <email>pbarreiro@v4066.drago.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Txagorritxu</name>
      <address>
        <city>Vitoria</city>
        <state>Alava</state>
        <zip>01009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joseba Portu, Dr.</last_name>
      <phone>+3494 5007000</phone>
      <phone_ext>5326</phone_ext>
      <email>jportu@htxa.osakidetza.net</email>
    </contact>
    <investigator>
      <last_name>Joseba Portu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel Aldamiz, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Elche</name>
      <address>
        <city>Elche</city>
        <state>Alicante</state>
        <zip>03203</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Clara Maria Escolano, Dr.</last_name>
      <phone>+34966 679 154</phone>
      <email>cescolanoh@coma.es</email>
    </contact>
    <investigator>
      <last_name>Clara Maria Escolano, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <state>Asturias</state>
        <zip>33006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Victor Asensi, Dr.</last_name>
      <phone>+34985108000</phone>
      <email>vasensia@medynet.com</email>
    </contact>
    <investigator>
      <last_name>Victor Asensi, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Son Dureta</name>
      <address>
        <city>Palma de Mallorca</city>
        <state>Baleares</state>
        <zip>07014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lucia Bonet, Dr.</last_name>
      <phone>+34971175000</phone>
      <email>lbonet@hsd.es</email>
    </contact>
    <investigator>
      <last_name>Lucia Bonet, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Escarda, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pere Vaquer, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Manuel Cervantes, Dr.</last_name>
      <phone>+34937231010</phone>
      <email>mcervantes@cspt.es</email>
    </contact>
    <investigator>
      <last_name>Manuel Cervantes, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Jerez de la Frontera</name>
      <address>
        <city>Jerez de la Frontera</city>
        <state>Cadiz</state>
        <zip>11407</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alberto Terrón</last_name>
      <phone>+34 956 032 062</phone>
      <email>jaterron@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Alberto Terrón, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Ruiz, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <state>Cantabria</state>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Santiago Echevarria, Dr.</last_name>
      <phone>+34942202669</phone>
      <email>mirevs@humv.es</email>
    </contact>
    <contact_backup>
      <last_name>Carmen Fariña, Dr.</last_name>
      <phone>+34942203375</phone>
      <email>mirfac@humv.es</email>
    </contact_backup>
    <investigator>
      <last_name>Santiago Echevarria, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carmen Fariña, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Fuerteventura</name>
      <address>
        <city>Puerto del Rosario</city>
        <state>Fuerteventura</state>
        <zip>35600</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jesús Flores, Dr.</last_name>
      <email>jfmagad@terra.es</email>
    </contact>
    <investigator>
      <last_name>Jesús Flores, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Doctor Negrín</name>
      <address>
        <city>Las Palmas de Gran Canarias</city>
        <state>Gran Canaria</state>
        <zip>35020</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rafael Granados, Dr.</last_name>
      <phone>+34928 450 683</phone>
      <email>rafagramon@wanadoo.es</email>
    </contact>
    <contact_backup>
      <last_name>Miguel Angel Cardenas, Dr.</last_name>
      <email>mcarsa2@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Rafael Granados, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel Ángel Cárdenas, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Arquitecto Marcide</name>
      <address>
        <city>Ferrol</city>
        <state>La Coruña</state>
        <zip>15405</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ana Mariño, Dr</last_name>
      <phone>+34981334000</phone>
      <email>ana.marino.callejo@sergas.es</email>
    </contact>
    <investigator>
      <last_name>Ana Mariño, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario</name>
      <address>
        <city>Santiago</city>
        <state>La Coruña</state>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Losada, Dr</last_name>
      <phone>+34981195266</phone>
      <email>elena.losada.arias@sergas.es</email>
    </contact>
    <contact_backup>
      <last_name>Arturo Prieto, Dr</last_name>
      <phone>+34981195266</phone>
      <email>arturo.prieto.martinez@sergas.es</email>
    </contact_backup>
    <investigator>
      <last_name>Elena Losada, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Alcorcon</name>
      <address>
        <city>Alcorcon</city>
        <state>Madrid</state>
        <zip>28922</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juan Emilio Losa, Dr.</last_name>
      <phone>+3491 6219400</phone>
      <email>jelosa@fhalcorcon.es</email>
    </contact>
    <investigator>
      <last_name>Juan Emilio Losa, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>María Velasco, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leonor Moreno, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Severo Ochoa</name>
      <address>
        <city>Leganés</city>
        <state>Madrid</state>
        <zip>28911</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rafael Rodriguez-Rosado, Dr.</last_name>
      <email>rafael.rrosado@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Rafael Rodriguez-Rosado, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Xeral-Cíes</name>
      <address>
        <city>Vigo</city>
        <state>Pontevedra</state>
        <zip>36204</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Celia Miralles, Dr</last_name>
      <phone>+34986816000</phone>
      <phone_ext>16104</phone_ext>
      <email>maria.celia.miralles.alvarez@sergas.es</email>
    </contact>
    <contact_backup>
      <last_name>Antonio Ocampo, Dr</last_name>
      <phone>+34986816000</phone>
      <phone_ext>16104</phone_ext>
      <email>aocampo@arrakis.es</email>
    </contact_backup>
    <investigator>
      <last_name>Celia Miralles, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonio Ocampo, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital do Meixoeiro</name>
      <address>
        <city>Vigo</city>
        <state>Pontevedra</state>
        <zip>36214</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luis Morano, Dr.</last_name>
      <phone>+34986 81 11 11</phone>
      <phone_ext>11386</phone_ext>
      <email>luis.morano.amado@sergas.es</email>
    </contact>
    <investigator>
      <last_name>Luis Morano, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Canarias</name>
      <address>
        <city>La Laguna</city>
        <state>Santa Cruz de Tenerife</state>
        <zip>38320</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Remedios Alemán, Dr.</last_name>
      <phone>+34922678000</phone>
      <email>mraleman@comtf.es</email>
    </contact>
    <contact_backup>
      <last_name>Juan Luis Gómez, Dr.</last_name>
      <phone>+34922678000</phone>
      <email>infecciones@huc.canarias.org</email>
    </contact_backup>
    <investigator>
      <last_name>Remedios Alemán, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan Luis Gómez Sirvent, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria del Mar Alonso, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana López Lirola, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de la Palma</name>
      <address>
        <city>La Palma</city>
        <state>Santa Cruz de Tenerife</state>
        <zip>38713</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vicente Pueyo, Dr.</last_name>
      <phone>+34922185372</phone>
      <email>vpueyo@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Vicente Pueyo, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Cruces</name>
      <address>
        <city>Baracaldo</city>
        <state>Vizcaya</state>
        <zip>48913</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Koldo Aguirrebengoa, Dr</last_name>
      <phone>+34946006379</phone>
      <email>kaguirrebengoa@hcru.osakidetza.net</email>
    </contact>
    <investigator>
      <last_name>Koldo Aguirrebengoa, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Juan Canalejo</name>
      <address>
        <city>A Coruña</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Angeles Castro, Dr.</last_name>
      <email>miriamca@udc.es</email>
    </contact>
    <contact_backup>
      <last_name>Jose Domingo Pedreira, Dr.</last_name>
      <email>MInternaB@canalejo.org</email>
    </contact_backup>
    <investigator>
      <last_name>Angeles Castro, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose Domingo Pedreira, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Soledad López, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Albacete</name>
      <address>
        <city>Albacete</city>
        <zip>02006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elisa Martínez Alfaro, Dr.</last_name>
      <phone>+34967 597 253</phone>
      <email>emartineza@ono.es</email>
    </contact>
    <investigator>
      <last_name>Elisa Martínez Alfaro, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Creu y Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josep Cadafalch, Dr.</last_name>
      <phone>+3493 556 56 24</phone>
      <email>jcadafalch@hsp.santpau.es</email>
    </contact>
    <contact_backup>
      <last_name>Josep Maria Guardiola, Dr.</last_name>
      <phone>+3493 556 56 24</phone>
      <email>jguardiola@hsp.santpau.es</email>
    </contact_backup>
    <investigator>
      <last_name>Josep Cadafalch, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Josep Maria Guardiola, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>María A. Sambeat, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pere Domingo, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico san Cecilio</name>
      <address>
        <city>Granada</city>
        <zip>18012</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jose Hernandez Quero, Dr.</last_name>
      <phone>+34958 249 079</phone>
      <email>jhquero@ugr.es</email>
    </contact>
    <investigator>
      <last_name>José Hernandez Quero, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alejandro Pena, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jorge Parra, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital San Jorge</name>
      <address>
        <city>Huesca</city>
        <zip>22004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Miguel Angel Berdú, Dr</last_name>
      <phone>+34974247000</phone>
      <email>med001689@saludalia.com</email>
    </contact>
    <investigator>
      <last_name>Miguel Angel Berdú, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel Egido, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Xeral-Caldé</name>
      <address>
        <city>Lugo</city>
        <zip>27004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juan Carlos Corredoira, Dr.</last_name>
      <phone>+34982 29 62 60</phone>
      <email>juan.corredoira.sanchez@sergas.es</email>
    </contact>
    <contact_backup>
      <last_name>Maria José Lopez, Dr.</last_name>
      <phone>+34982 29 62 60</phone>
      <email>mariajose.lopez.alvarez@sergas.es</email>
    </contact_backup>
    <investigator>
      <last_name>Juan Carlos Corredoira, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria José Lopez, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de la Princesa</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ignacio Santos, Dr.</last_name>
      <phone>+3491 5202236</phone>
      <email>isantosg@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Ignacio Santos, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raquel Carrillo, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pilar Miralles, Dr.</last_name>
      <email>pmiralles.hgugm@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Pilar Miralles, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Carlos III</name>
      <address>
        <city>Madrid</city>
        <zip>28029</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicente Soriano, Dr</last_name>
      <phone>+34914532500</phone>
      <email>vsoriano@dragonet.es</email>
    </contact>
    <contact_backup>
      <last_name>Pablo Barreiro, Dr</last_name>
      <phone>+34914532500</phone>
      <email>pbarreiro@v4066.drago.net</email>
    </contact_backup>
    <investigator>
      <last_name>Vicente Soriano, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pablo Barreiro, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pablo Labarga, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luz Martin-Carbonero, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Javier García-Samaniego, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>José Martínez Alarcón, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sonia Rodríguez Novoa, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eugenia Vispo, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Jesús Téllez, Dr.</last_name>
      <phone>+3491 3303538</phone>
      <email>mjtellezm@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Maria Jesús Téllez, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vicente Estrada, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jorge Verga, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mónica Fuster, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rafael Rubio, Dr.</last_name>
      <phone>+3491 390 80 28</phone>
      <email>rrubiog@saludalia.com</email>
    </contact>
    <investigator>
      <last_name>Rafael Rubio, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Maria del Rosell</name>
      <address>
        <city>Murcia</city>
        <zip>30203</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jose Adolfo Garcia Henarejos, Dr.</last_name>
      <phone>+34968325226</phone>
    </contact>
    <investigator>
      <last_name>Jose Adolfo Garcia Henarejos, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Virgen de la Victoria</name>
      <address>
        <city>Málaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mercedes González, Dr.</last_name>
      <phone>+34952 649 393</phone>
      <email>med006801@saludalia.com</email>
    </contact>
    <investigator>
      <last_name>Mercedes Gonzalez, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Josefa Ruiz, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jesús Santos, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuel Márquez, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <zip>37007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alicia Iglesias, Gómez</last_name>
      <phone>+34923291100</phone>
      <email>a_iglesias74@yahoo.es</email>
    </contact>
    <contact_backup>
      <last_name>Miguel Cordero, Dr.</last_name>
      <phone>+34923291100</phone>
      <email>magnus@usal.es</email>
    </contact_backup>
    <investigator>
      <last_name>Alicia Iglesias, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel Cordero, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de la Candelaria</name>
      <address>
        <city>Santa Cruz de Tenerife</city>
        <zip>38010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcelino Hayek, Dr.</last_name>
      <phone>+34922 60 20 21</phone>
      <email>ihayper@gobiernodecanarias.org</email>
    </contact>
    <investigator>
      <last_name>Marcelino Hayek, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria José Rios, Dr.</last_name>
      <phone>+34955 008 520</phone>
      <email>MJRIOSVILLEGAS@terra.es</email>
    </contact>
    <investigator>
      <last_name>Maria José Rios, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angel Domínguez, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Valme</name>
      <address>
        <city>Sevilla</city>
        <zip>41014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juan Antonio Pineda, Dr.</last_name>
      <phone>+34955 015 887</phone>
      <email>japineda@telefonica.net</email>
    </contact>
    <investigator>
      <last_name>Juan Antonio Pineda, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fernando Lozano de León, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan Macías, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eva Recio, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario la Fé</name>
      <address>
        <city>Valencia</city>
        <zip>46009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José La Cruz, Dr.</last_name>
      <phone>+3496 386 27 00</phone>
      <phone_ext>40352</phone_ext>
      <email>lacruz_jos@gva.es</email>
    </contact>
    <investigator>
      <last_name>José La Cruz, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>José López-Aldeguer, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marino Blanes, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel Salvert, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eva Calabuig, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marta Montero, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Cuellar, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospial Clinico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria José Galindo, Dr.</last_name>
      <phone>+34963862600</phone>
      <email>pepagal@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Maria José Galindo, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>José Gaix, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <zip>47011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Miguel Angel del Pozo, Dr.</last_name>
      <phone>+34983420000</phone>
      <phone_ext>343</phone_ext>
      <email>&quot;mdelpozo@med.uva.es mdelpozo@med.uva.es</email>
    </contact>
    <contact_backup>
      <last_name>Isabel González Gilabert, Dr.</last_name>
      <phone>+34983420000</phone>
      <phone_ext>343</phone_ext>
      <email>isabel46@ono.com</email>
    </contact_backup>
    <investigator>
      <last_name>Miguel Angel del Pozo, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabel González Gilabert, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario Lozano Blesa</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Isabel Sanjoaquín, Dr.</last_name>
      <phone>+34976 556400</phone>
      <phone_ext>2664</phone_ext>
      <email>isanjoaquin@able.es</email>
    </contact>
    <contact_backup>
      <last_name>Santiago Letona, Dr.</last_name>
      <email>santiagoletona@yahoo.es</email>
    </contact_backup>
    <investigator>
      <last_name>Isabel Sanjoaquín, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Santiago Letona, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan Antonio Amiguet, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julián Cuesta, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>María José Crusells, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carlos Ramos, Dr.</last_name>
      <email>cramosp@salud.aragon.es</email>
    </contact>
    <investigator>
      <last_name>Carlos Ramos, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Piedad Arazo, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ascensión Pascual, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Desiré Gil, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>José Miguel Aguirre, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2007</study_first_submitted>
  <study_first_submitted_qc>September 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2007</study_first_posted>
  <last_update_submitted>January 28, 2009</last_update_submitted>
  <last_update_submitted_qc>January 28, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 29, 2009</last_update_posted>
  <keyword>high dose of ribavirin</keyword>
  <keyword>extend treatment duration</keyword>
  <keyword>tailoring treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Hepatitis, Chronic</mesh_term>
    <mesh_term>Hepatitis C, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ribavirin</mesh_term>
    <mesh_term>Peginterferon alfa-2a</mesh_term>
    <mesh_term>Interferon-alpha</mesh_term>
    <mesh_term>Epoetin Alfa</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

